Cargando…

Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7

Point mutations in the genes encoding the skeletal muscle isoforms of tropomyosin can cause a range of muscle diseases. The amino acid substitution of Arg for Pro residue in the 90th position (R90P) in γ-tropomyosin (Tpm3.12) is associated with congenital fiber type disproportion and muscle weakness...

Descripción completa

Detalles Bibliográficos
Autores principales: Borovikov, Yurii S., Andreeva, Daria D., Avrova, Stanislava V., Sirenko, Vladimir V., Simonyan, Armen O., Redwood, Charles S., Karpicheva, Olga E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231546/
https://www.ncbi.nlm.nih.gov/pubmed/34204776
http://dx.doi.org/10.3390/ijms22126318
_version_ 1783713449618964480
author Borovikov, Yurii S.
Andreeva, Daria D.
Avrova, Stanislava V.
Sirenko, Vladimir V.
Simonyan, Armen O.
Redwood, Charles S.
Karpicheva, Olga E.
author_facet Borovikov, Yurii S.
Andreeva, Daria D.
Avrova, Stanislava V.
Sirenko, Vladimir V.
Simonyan, Armen O.
Redwood, Charles S.
Karpicheva, Olga E.
author_sort Borovikov, Yurii S.
collection PubMed
description Point mutations in the genes encoding the skeletal muscle isoforms of tropomyosin can cause a range of muscle diseases. The amino acid substitution of Arg for Pro residue in the 90th position (R90P) in γ-tropomyosin (Tpm3.12) is associated with congenital fiber type disproportion and muscle weakness. The molecular mechanisms underlying muscle dysfunction in this disease remain unclear. Here, we observed that this mutation causes an abnormally high Ca(2+)-sensitivity of myofilaments in vitro and in muscle fibers. To determine the critical conformational changes that myosin, actin, and tropomyosin undergo during the ATPase cycle and the alterations in these changes caused by R90P replacement in Tpm3.12, we used polarized fluorimetry. It was shown that the R90P mutation inhibits the ability of tropomyosin to shift towards the outer domains of actin, which is accompanied by the almost complete depression of troponin’s ability to switch actin monomers off and to reduce the amount of the myosin heads weakly bound to F-actin at a low Ca(2+). These changes in the behavior of tropomyosin and the troponin–tropomyosin complex, as well as in the balance of strongly and weakly bound myosin heads in the ATPase cycle may underlie the occurrence of both abnormally high Ca(2+)-sensitivity and muscle weakness. BDM, an inhibitor of myosin ATPase activity, and W7, a troponin C antagonist, restore the ability of tropomyosin for Ca(2+)-dependent movement and the ability of the troponin–tropomyosin complex to switch actin monomers off, demonstrating a weakening of the damaging effect of the R90P mutation on muscle contractility.
format Online
Article
Text
id pubmed-8231546
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82315462021-06-26 Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7 Borovikov, Yurii S. Andreeva, Daria D. Avrova, Stanislava V. Sirenko, Vladimir V. Simonyan, Armen O. Redwood, Charles S. Karpicheva, Olga E. Int J Mol Sci Article Point mutations in the genes encoding the skeletal muscle isoforms of tropomyosin can cause a range of muscle diseases. The amino acid substitution of Arg for Pro residue in the 90th position (R90P) in γ-tropomyosin (Tpm3.12) is associated with congenital fiber type disproportion and muscle weakness. The molecular mechanisms underlying muscle dysfunction in this disease remain unclear. Here, we observed that this mutation causes an abnormally high Ca(2+)-sensitivity of myofilaments in vitro and in muscle fibers. To determine the critical conformational changes that myosin, actin, and tropomyosin undergo during the ATPase cycle and the alterations in these changes caused by R90P replacement in Tpm3.12, we used polarized fluorimetry. It was shown that the R90P mutation inhibits the ability of tropomyosin to shift towards the outer domains of actin, which is accompanied by the almost complete depression of troponin’s ability to switch actin monomers off and to reduce the amount of the myosin heads weakly bound to F-actin at a low Ca(2+). These changes in the behavior of tropomyosin and the troponin–tropomyosin complex, as well as in the balance of strongly and weakly bound myosin heads in the ATPase cycle may underlie the occurrence of both abnormally high Ca(2+)-sensitivity and muscle weakness. BDM, an inhibitor of myosin ATPase activity, and W7, a troponin C antagonist, restore the ability of tropomyosin for Ca(2+)-dependent movement and the ability of the troponin–tropomyosin complex to switch actin monomers off, demonstrating a weakening of the damaging effect of the R90P mutation on muscle contractility. MDPI 2021-06-12 /pmc/articles/PMC8231546/ /pubmed/34204776 http://dx.doi.org/10.3390/ijms22126318 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Borovikov, Yurii S.
Andreeva, Daria D.
Avrova, Stanislava V.
Sirenko, Vladimir V.
Simonyan, Armen O.
Redwood, Charles S.
Karpicheva, Olga E.
Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7
title Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7
title_full Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7
title_fullStr Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7
title_full_unstemmed Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7
title_short Molecular Mechanisms of the Deregulation of Muscle Contraction Induced by the R90P Mutation in Tpm3.12 and the Weakening of This Effect by BDM and W7
title_sort molecular mechanisms of the deregulation of muscle contraction induced by the r90p mutation in tpm3.12 and the weakening of this effect by bdm and w7
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231546/
https://www.ncbi.nlm.nih.gov/pubmed/34204776
http://dx.doi.org/10.3390/ijms22126318
work_keys_str_mv AT borovikovyuriis molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7
AT andreevadariad molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7
AT avrovastanislavav molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7
AT sirenkovladimirv molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7
AT simonyanarmeno molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7
AT redwoodcharless molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7
AT karpichevaolgae molecularmechanismsofthederegulationofmusclecontractioninducedbyther90pmutationintpm312andtheweakeningofthiseffectbybdmandw7